Cossins Benjamin P, Lawson Alastair D G, Shi Jiye
Computer-Aided Drug Design and Structural Biology, UCB Pharma, Slough, UK.
Methods Mol Biol. 2018;1762:339-365. doi: 10.1007/978-1-4939-7756-7_17.
Protein drug targets vary from highly structured to completely disordered; either way dynamics governs function. Hence, understanding the dynamical aspects of how protein targets function can enable improved interventions with drug molecules. Computational approaches offer highly detailed structural models of protein dynamics which are becoming more predictive as model quality and sampling power improve. However, the most advanced and popular models still have errors owing to imperfect parameter sets and often cannot access longer timescales of many crucial biological processes. Experimental approaches offer more certainty but can struggle to detect and measure lightly populated conformations of target proteins and subtle allostery. An emerging solution is to integrate available experimental data into advanced molecular simulations. In the future, molecular simulation in combination with experimental data may be able to offer detailed models of important drug targets such that improved functional mechanisms or selectivity can be accessed.
蛋白质药物靶点的结构从高度有序到完全无序各不相同;无论哪种情况,动力学都决定着功能。因此,了解蛋白质靶点发挥功能的动力学方面,有助于改进药物分子的干预效果。计算方法提供了蛋白质动力学的高度详细的结构模型,随着模型质量和采样能力的提高,这些模型的预测性也越来越强。然而,由于参数集不完善,最先进、最流行的模型仍然存在误差,而且往往无法触及许多关键生物过程的更长时间尺度。实验方法能提供更高的确定性,但在检测和测量目标蛋白质的低丰度构象以及微妙的变构效应方面可能会遇到困难。一种新兴的解决方案是将现有的实验数据整合到先进的分子模拟中。未来,分子模拟与实验数据相结合或许能够提供重要药物靶点的详细模型,从而深入了解改进后的功能机制或选择性。